“Many scientists believe that this year could be a breakthrough in finding cures for cancer in DNA and investors could get familiar with terms like CRISPR and precision medicine to make the most out of advancements in this space.”
Three biotech companies developing therapies for the treatment of cancer and other diseases – including infectious diseases like COVID-19 – began trading on Friday.
“Make no mistake: These stocks are risky. Nonetheless, each of these companies has a few factors in its favor aside from being popular with retail traders, so if you’re looking for a high-risk and high-reward stock to add to your portfolio, one of these might be worth buying,”
Which biotech stocks will be the next to reward risk-tolerant investors with massive returns?
The four penny stocks highlighted in today’s article are all biopharmaceutical/biotech companies, they can all be bought for under $4, and they all have important upcoming events.
“September has historically been the worst-performing month for stocks – and today’s article identifies the stocks that have shown themselves to be the worst stocks to own in September over the past 10 years.
Biotech Start-ups poised to take off in the next 12 months.
Profitable Biotech Stocks with a high probability of putting profits in your pocket right now.
Biotech IPOs have helped drug developers raise over $5 billion so far this year.
Top five mid-cap companies that have been experiencing insider buying amid the coronavirus crisis.